Download overview diagram: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95920337
Browse the detailed table of contents on “Biopharmaceutical Process Analytical Technology Market”.
168 – table
52 – Figure
255 – Page
Biopharmaceutical process analysis technology market range:
Report scope |
detail |
Market revenue in 2024 |
$1.2 billion |
Estimates until 2029 |
$2.6 billion |
growth rate |
Expected to grow at a CAGR of 16.0% |
Available market size |
2022-2029 |
Forecast period |
2024-2029 |
prediction unit |
Value (US$ billion) |
Report scope |
Revenue forecast, competitive environment, growth factors, trends |
Target segment |
Type, product type, mode, application, and region |
Target area |
North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
Report highlights |
Updated player financial information/product portfolio |
Key market opportunities |
Medical costs are rising in developing countries |
Key market drivers |
Increasing demand for improved quality of manufacturing processes |
The liquid chromatography/HPLC segment is anticipated to register significant growth rate over the forecast period 2024-2029.
Based on type, the global biopharmaceutical process analysis market is segmented into liquid chromatography/HPLC, gas chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, Raman spectroscopy, infrared spectroscopy, particle counters and It is categorized into the imaging segment. , differential light scattering, and other techniques. The liquid chromatography/HPLC segment is expected to see significant growth. The widespread use of chromatography in the biopharmaceutical field spans tasks such as quantifying pharmaceutical compounds, identifying pathogens, measuring proteins, and supporting biochemical and biophysical research, highlighting its importance . Additionally, stringent regulatory standards governing drug development and safety play a key role in driving the company's global growth.
In the market by product type in 2023, the analytical instruments segment accounted for the largest share in biopharmaceutical process analysis technology.
Based on product type, the analyzer segment is dominating the biopharmaceutical process analysis technology market and this trend is expected to continue during the forecast period. In 2023, this sector gained the largest share due to advances in process analysis technology. This has increased operational efficiency and reduced process cycle times.
In 2023, the online analytics segment dominated the market in terms of measurement.
Based on mode, the dominant segment of the biopharmaceutical process analysis technology tools market in 2023 was online analysis. Fast processing and reliable results are due to efficient monitoring of critical process parameters (CPPs) throughout drug development and manufacturing. To effectively analyze CPP, various analysis methods were utilized, including online, inline, at-line, and offline approaches.
North America The market is expected to hold a major share in the market during the forecast period.
Based on region, North Americawith the United States Canadawill account for the largest share of the global biopharmaceutical process analysis technology market in 2023. The major factors driving this market include the availability of research funding, stringent regulations overseeing drug development, and increasing prevalence of central conferences, discussions, symposiums, and seminars. Focusing on analytical technology.
Request a sample page: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95920337
Biopharmaceutical Process Analysis Technology Market Dynamics:
driver:
- Increasing demand for improved quality of manufacturing processes
Restraint:
- The cost of implementing PAT is high
opportunity:
- Medical costs are rising in developing countries
Challenge:
- lack of skilled professionals
major market players Biopharmaceutical process analysis technology industry:
As of 2023, the prominent players in the biopharmaceutical process analysis technology market are Waters Corporation (USA), Thermo Fisher Scientific (USA), Danaher Corporation (USA), Agilent Technologies (USA), Shimadzu Corporation (Japan), Bruker Corporation (USA), Emerson Electric Co. (USA), ABB Ltd. (Switzerland), PerkinElmer, Inc. (USA), Mettler-Toledo International Inc. (USA), and Carl Zeiss AG (Germany)Such.
The breakdown of key participants referenced in this report is as follows:
- By company type: Tier 1 30%, Tier 2-42%, Tier 3-28%
- By designation: C Level – 14%, D Level – 10%, Other – 76%
- By region: North America – 40%, Europe – 30%, Asia Pacific – 22%, Latin America – 6%, middle east and Africa – 2%
Get 10% free customization on this report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95920337
Recent developments in the biopharmaceutical process analysis technology industry:
- in February 2024, Thermo Fisher Scientific Inc. has introduced the Thermo Scientific Dionex Inuvion ion chromatography (IC) system to simplify and enhance ion analysis across laboratories of various sizes. This innovative analytical instrument offers easy reconfiguration and serves as a comprehensive solution for accurately measuring ionic and low polar compounds, ensuring consistent and reliable results.
- in April 2022Thermo Fisher Scientific Inc. has introduced the Lamina Process Analyzer, a Raman spectrometer. Raman spectrometers aim to simplify Raman spectroscopy measurements to reduce complexity and increase user accessibility.
- in June 2021Agilent Technologies Inc. has launched three InfinityLab Bio LC systems, which the company has introduced to meet the growing demands of the biopharmaceutical field.
Biopharmaceutical Process Analysis Technology Market – Key Benefits of Purchasing the Report:
This report will enable established companies as well as new entrants and small businesses to understand the market trends and in turn will help them capture a larger market share. Companies purchasing this report can use one or a combination of the strategies listed below to strengthen their market presence.
This report provides insight into the following guidelines:
- Market Penetration: Comprehensive information on product portfolios offered by top players in the Biopharmaceutical Process Analytical Technology market
- Product Development/Innovation: Detailed insights into upcoming trends, R&D activities, and product launches in the biopharmaceutical process analysis technology market
- Market Development: Comprehensive information on profitable emerging regions
- Market Diversification: Thorough Information on New Products, Growth Regions, and Recent Developments in the Biopharmaceutical Process Analytical Technology Market
- Competitive assessment: Detailed assessment of market segments, growth strategies, revenue analysis, and products of key market players.
Related reports:
Biomarker Market – Global Forecast to 2028
Epigenetics Market – Global Forecast to 2028
Preimplantation Genetic Testing Market – Global Forecast to 2028
Molecular Diagnostics Market – Global Forecast to 2028
Life Science Equipment Market – Global Forecast to 2028
Access the latest information about biopharmaceutical process analysis technology companies and the biopharmaceutical process analysis technology industry.
About MarketsandMarkets™:
MarketsandMarkets™ is recognized as one of: America's Best Management Consulting Firm by Forbes Magazineaccording to their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, powered by man-machine services that drive paranormal growth for progressive organizations in the B2B space. We have the broadest perspective on emerging technologies and are adept at co-creating paranormal growth for our clients.
Earlier this year, we officially transformed into one of America's top management consulting firms, according to a survey conducted by Forbes.
In the B2B economy, 25 trillion dollars In the past decade alone, we have seen an increase in new revenue streams replacing existing ones. We work with our clients on growth programs and help them monetize this. 25 trillion dollars We offer opportunities through our service lines, including TAM expansion, go-to-market (GTM) strategy-to-execution, market share capture, account activation, and thought leadership marketing.
Built on the principles of GIVE Growth, we work with several Forbes Global 2000 B2B companies to help them stay relevant in a disruptive ecosystem. Masu. Our insights and strategies are shaped by industry experts, a cutting-edge AI-powered market intelligence cloud, and years of research. KnowledgeStore™, our Market Intelligence Cloud, integrates our research and facilitates analysis of interconnections across a suite of applications, allowing our clients to see the entire ecosystem and understand the revenue changes occurring in their industry. will help you.
For more information, visit www.MarketsandMarkets™.com or follow us below. twitterLinkedIn, Facebook.
contact:
Mr. Ashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
northbrook illinois 60062
united states of america: +1-888-600-6441
Email: [email protected]
Visit our website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
Source MarketsandMarkets